SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-14
👔
Liminatus Pharma, Inc.
@LIMN_InsiderForm 4 Filing: Valetudo Therapeutics LLC Acquires shares of $LIMN
INSIDER TRANSACTION
⚡ MATERIALITY: 1/10
corporate issuer
Liminatus Pharma, Inc.
Ticker: $LIMN
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-02
Shares: 3,448,926
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Valetudo Therapeutics LLC, holds the title of 10% Owner at Liminatus Pharma, Inc..
On 2026-07-02, the insider transacted 3,448,926 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Valetudo Therapeutics LLC (10% Owner) transacted $0 of $LIMN
Post-Transaction Position: 5,244,351 shares
SEC Accession No: 0001104659-26-083588 (CIK: 2067359)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.